New AI platform identifies which patients are likely to benefit most from a clinical trial

A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a particular therapy being tested in a clinical trial. This AI platform can help with making informed treatment decisions, understanding the expected benefits of novel therapies and planning future care.

from Top Health News -- ScienceDaily https://ift.tt/wMbOWUB